Solid Biosciences Inc. brings patient advocates to FA panel at GMP Lab

Solid Biosciences Inc. brings patient advocates to FA panel at GMP Lab
Solid Biosciences Inc. holds FA panel

Solid Biosciences Inc. recently convened with patient advocates at a panel hosted at PPDCRO's GMP Lab in Middleton, Wisconsin.

The meeting focused on direct experiences of those impacted by Friedreichs Ataxia, aiming to foster deeper connections and collaboration between the company and the FA community. Solid Biosciences Inc. shared insights into its ongoing work related to Friedreichs Ataxia, emphasizing a commitment to engaging with patient voices as part of their approach to rare disease research. Details about next steps and outcomes from the discussion are not yet public.

Solid Biosciences Inc. previously teamed up with FARA and the Boston community for rideATAXIA, supporting Friedreich's ataxia research. The company also reported its financial results for the second quarter of 2026 along with updates on its development pipeline. These recent efforts demonstrate an ongoing focus on both research and engagement with the Friedreich's ataxia community.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.